How to develop a TB lab management review meeting agenda and report template
A well-designed management review meeting gives a tuberculosis laboratory a structured opportunity to examine performance, risks, resources and improvement work. It turns routine quality data into decisions that managers, scientists, quality officers and support teams can act on.
Knowing how to develop a TB lab management review meeting agenda and report template is especially valuable in Australia, where laboratories may operate within state or territory health systems, private pathology networks, hospital services or remote regional programs. The format should support NATA expectations, ISO 15189 principles and the practical realities of TB testing across metropolitan and rural settings.
| Meeting component | Main evidence | Required output |
|---|---|---|
| Quality performance | Turnaround times, error rates, rejected specimens and amended reports | Agreed interpretation and priorities |
| Technical work | Culture, microscopy, molecular testing and susceptibility testing | Technical risks and actions |
| Resources | Staffing, competency, equipment, supplies and contracts | Resourcing decisions |
| Safety and compliance | Incidents, exposure risks, audits and corrective actions | Controls, owners and deadlines |
| Improvement programme | Previous actions, indicators and project updates | Continued, closed or escalated actions |
| Meeting governance | Attendees, decisions and review date | Approved minutes and action register |
Define the purpose and scope
Begin by stating what the meeting is intended to achieve. A TB laboratory management review should assess whether the quality management system remains suitable, effective and adequately resourced. It should also identify risks that could affect accurate, timely and clinically useful results.
Set a regular schedule that matches the laboratory’s workload and risk profile. Quarterly reviews are often practical, with shorter monthly operational meetings for urgent issues. A service supporting hospitals in Sydney or Melbourne may need a different rhythm from a small facility serving communities across the Northern Territory or regional Western Australia.
The scope should cover the complete testing pathway, from specimen collection and transport through reporting, referral testing and post-result communication. Include laboratory safety, personnel, equipment, purchasing, documents, information management, assessment and continual improvement rather than limiting the discussion to analytical results.
Gather reliable inputs before the meeting
The chair or quality manager should issue an agenda and request evidence well before the meeting. Useful inputs include internal audit findings, external quality assessment results, incident reports, customer feedback, complaints, nonconformities, equipment downtime, stock shortages and staff competency records.
TB-specific data might include the number of specimens received, contamination rates, invalid molecular results, culture positivity, turnaround times and delays in drug susceptibility testing. Results should be separated by test method and specimen type where this reveals a meaningful pattern. A single overall percentage can conceal a problem affecting one instrument or one referral pathway.
Australian laboratories should also consider transport conditions and geography. A delayed courier from a remote Queensland or Western Australian site may create a different risk from a delayed specimen within metropolitan Brisbane. Include relevant information from courier providers, hospital collection services, state TB programs and reference laboratories.
The phase checklists can help teams organise evidence against the quality systems essentials and identify which issues belong on the management review agenda. Use them as a prompt, then tailor the evidence to the laboratory’s scope and current phase of development.
Build an agenda that leads to decisions
A useful agenda moves from facts to analysis and then to decisions. Start with attendance, apologies, conflicts of interest and approval of the previous report. Follow with a review of outstanding actions, since unresolved items often show where ownership, funding or escalation is weak.
Next, review performance indicators and significant events. Place high-risk matters early rather than leaving them for the final minutes. The agenda may then address audit outcomes, staff capability, equipment and facilities, purchasing, document changes, safety, customer feedback and opportunities for improvement.
Every item should show a presenter, required preparation and the decision sought. “Review contamination rate” is less useful than “Decide whether the rising contamination rate requires retraining, a specimen collection review or additional clinical liaison.” This wording keeps the meeting focused and prevents a long report from becoming a passive information session.
Allow time for cross-functional discussion. A laboratory scientist may identify a technical issue, while a procurement officer knows that a replacement reagent is unavailable through the usual Australian supplier. The agenda should make space for those connections.
Set roles and meeting controls
The laboratory manager normally chairs the meeting, while the quality manager prepares the papers, records decisions and maintains the action register. Include representatives from technical areas, specimen reception, safety, clinical services, information technology and administration when their decisions affect quality.
For a small regional service, one person may hold several roles. That is acceptable if responsibilities are clear and conflicts are managed. Invite a state reference laboratory or public health representative when the review involves referral testing, outbreaks or complex drug resistance.
Use a controlled agenda template with a document number, version, meeting date and approval status. Circulate papers early, identify confidential material and record attendance accurately. Minutes should distinguish discussion from decisions, because an observation is not the same as an approved corrective action.
Close each item with an explicit outcome: accepted, action required, referred, monitored or closed. This simple vocabulary improves consistency across meetings and makes later audits easier to follow.
Design the management review report
The report should be shorter than the evidence pack and focused on conclusions. Start with the meeting date, scope, attendees, documents reviewed and a concise summary of significant changes since the previous review.
For each agenda item, use a repeatable structure:
- Evidence reviewed
- Current status or trend
- Risk or implication
- Decision made
- Action owner
- Due date
- Follow-up measure
Add a dashboard for key indicators, using traffic-light status only when the criteria are defined. For example, green might mean a target was achieved, amber may indicate a deteriorating trend, and red may represent a breach requiring escalation. Include the actual value and reporting period so that colour does not replace evidence.
The report should capture management decisions about staffing, training, equipment replacement, infrastructure, supplier performance and improvement projects. If a new platform is being considered for a laboratory in Perth, document the validation requirements, budget source, service contract, training needs and transition risks rather than recording only “instrument under review.”
Use recommendations that can be tracked
Recommendations should be specific enough to enter directly into an action register. Avoid entries such as “improve documentation” or “monitor turnaround time.” State what will change, who will do it, how completion will be demonstrated and when effectiveness will be checked.
A practical recommendations section can include:
- Review specimen transport from remote collection sites and report findings by an agreed date
- Complete targeted competency assessment for staff performing molecular TB testing
- Investigate repeated invalid results on a named platform and document the root cause
- Confirm minimum stock levels and an alternate supplier for critical reagents
- Present a trend analysis of contamination and turnaround time at the next review
Prioritise actions according to patient impact, biosafety risk, regulatory significance and operational urgency. A low-cost document correction may be completed quickly, while replacing a biosafety cabinet requires capital approval, procurement and installation planning.
Assign one accountable owner to each action, even when several people contribute. The report can list supporting roles, but shared ownership without a named lead commonly causes delays.
Review performance, risk and improvement together
Management review is most useful when indicators are interpreted alongside risks and resources. A stable turnaround time may appear positive until the team discovers that staff are routinely working overtime or that urgent specimens are being prioritised at the expense of routine surveillance.
Include external changes that may affect the service, such as revised national guidance, state laboratory policies, workforce shortages, changes in referral arrangements or new molecular testing platforms. In Australia, service continuity may depend on local procurement, interstate transport and access to specialist expertise, particularly for laboratories outside Canberra, Sydney, Melbourne, Brisbane, Adelaide and Perth.
Check whether previous actions achieved their intended effect. If retraining reduced transcription errors for one month but the rate has since increased, the action should be reopened or redesigned. Effectiveness review prevents a laboratory from treating task completion as evidence that risk has been controlled.
The GLI Quality Tool provides a broader quality improvement framework that can help align meeting discussions with the twelve Quality Systems Essentials. Use that framework to connect individual findings with the laboratory’s wider maturity and continual improvement programme.
Put the template into practice
Before the first meeting, test the agenda with a small group and remove sections that generate no useful evidence. Keep the final format stable enough to support comparison between review periods, while allowing additional agenda items for outbreaks, major incidents, accreditation findings or significant service changes.
After approval, distribute the report to relevant personnel and update the quality improvement plan, risk register and action log. At the next meeting, begin with overdue and high-risk actions so that accountability remains visible. A clear report should make it easy for a new manager, auditor or external reviewer to understand what was considered and why decisions were made.
Use the finished template as a controlled document within the laboratory’s quality system. Adapt its terminology to local governance arrangements, validate it with the responsible manager and quality lead, and schedule the first review with enough time for meaningful evidence gathering. A consistent agenda and decision-focused report can turn management review into a practical mechanism for safer testing, stronger compliance and more reliable TB results.